<DOC>
	<DOCNO>NCT01386593</DOCNO>
	<brief_summary>The purpose study assess pharmacokinetic profile drug cocktail six approve drug ( so-called `` Basel cocktail '' ) change cytochrome P450 system inhibit induced .</brief_summary>
	<brief_title>Pharmacokinetic Study Characterize Phenotyping Metrics `` Basel '' Cocktail After CYP Induction Inhibition</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>Male age 18 35 year ( inclusive ) screening . No clinically significant finding physical examination screening . Body mass index ( BMI ) 18 28 kg/m2 ( inclusive ) body weight least 50 kg screening . Systolic blood pressure ( SBP ) 100145 mmHg , diastolic blood pressure ( DBP ) 5090 mmHg heart rate ( HR ) 4590 bpm ( inclusive ) . 12lead electrocardiogram ( ECG ) without clinically relevant abnormality screen . Hematology clinical chemistry result deviate normal range clinically relevant extent screening . Ability communicate well investigator understand comply requirement study . Known hypersensitivity excipients drug formulation . Treatment another investigational drug within 30 day prior screen . History clinical evidence alcoholism drug abuse within 3year period prior screen . Positive result urine drug screen screen . Excessive caffeine consumption , define &gt; 800 mg per day screening* . African Hispanic ethnicity . History clinical evidence disease and/or existence surgical medical condition , might interfere absorption , distribution , metabolism excretion study drug , might increase risk toxicity . Smoking within last 3 month prior screen . Previous treatment prescribe OTC medication ( include herbal medicine St John 's Wort ) within 2 week prior intend start study . Loss 250 ml blood within 3 month prior screen . Any circumstance condition , , opinion investigator , may affect full participation study compliance protocol . Legal incapacity limit legal capacity screening .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Cytochrome</keyword>
	<keyword>Phenotyping</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>